logo/base Created with Sketch.

FibroScan® Compact 530

The portable non-invasive solution for efficient liver disease management

Powered by LSM by VCTE™ and CAP™ for liver disease management.

wave

From cart-based to transportable

With its optional roll stand, 15” interactive touchscreen display and durable ergonomic design, FibroScan® Compact 530 is the perfect liver assessment solution for any point-of-care setting.

Adaptive design and ergonomics

LSM by VCTE™ is unique, patented and validated for Liver Stiffness Measurement1. 2,250 peer-reviewed publications support the use of LSM by VCTE™.

CAPTM is unique patented and validated for liver disease management. 330 international peer-reviewed publications support the use of CAP™.

 

What our users say

quote

As a clinical researcher, I rely heavily on FibroScan® to select the right patient for the right study. Clinical trials in non-alcoholic steatohepatitis typically include patients with specific fibrosis stages. It is thus important to have reliable fibrosis assessment and avoid unnecessary liver biopsies.

Vincent Wong | Hepatologist from Hong Kong

chevron chevron

FibroScan® 530 Compact Indications for Use

The FibroScan® 530 Compact is intended to provide 50Hz shear wave speed measurements and estimates of tissue stiffness as well as 3.5 MHz ultrasound coefficient of attenuation (CAP: Controlled Attenuation Parameter) in internal structures of the body. The FibroScan® 530 Compact is indicated for noninvasive measurement in the liver of 50 Hz shear wave speed and estimates of stiffness as well as determining a 3.5 MHz ultrasound coefficient for the Attenuation Parameter (CAP: Controlled Attenuation Parameter). The shear wave speed and stiffness, and CAP may be used as an aid to diagnosis and monitoring of adult patients with liver disease, as part of an overall assessment of the liver. Shear wave speed and stiffness may be used as an aid in the clinical management of pediatric patients with liver disease.

 

References are available in our bibliography.